Evidence map›Paper›PMID 41791287›Full record

ArticleJACC. Advances2026

Clinical Characteristics and Cardiac Magnetic Resonance Profile of PKP2 Variant-Positive Patients With a Hypertrophic Cardiomyopathy Phenotype.

Matteo Castrichini, Ramin Garmany, Konstantinos C Siontis, Darrell B Newman, Jeffrey B Geske, Steve R Ommen, Jay Schneider, Leslie T Cooper, Michael J Ackerman, John R Giudicessi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matteo CastrichiniDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ramin GarmanyMayo Clinic Medical Scientist Training Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.
Konstantinos C SiontisDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Darrell B NewmanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jeffrey B GeskeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Steve R OmmenDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jay SchneiderDepartment of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Leslie T CooperDepartment of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Michael J AckermanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA; Department of Pediatrics (Division of Pediatric Cardiology), Rochester, Minnesota, USA.
John R GiudicessiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA. Electronic address: giudicessi.john@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arrhythmogenic cardiomyopathygeneticshypertrophic cardiomyopathyPKP2

Identifiers

PMID41791287
PMCPMC12993116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.